These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30034529)

  • 1. Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis.
    Tham YS; Yung DE; Fay S; Yamamoto T; Ben-Horin S; Eliakim R; Koulaouzidis A; Kopylov U
    Therap Adv Gastroenterol; 2018; 11():1756284818785571. PubMed ID: 30034529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn's Disease: Systematic Review and Meta-Analysis.
    Yung DE; Har-Noy O; Tham YS; Ben-Horin S; Eliakim R; Koulaouzidis A; Kopylov U
    Inflamm Bowel Dis; 2017 Dec; 24(1):93-100. PubMed ID: 29272490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis.
    Kopylov U; Yung DE; Engel T; Avni T; Battat R; Ben-Horin S; Plevris JN; Eliakim R; Koulaouzidis A
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1137-44. PubMed ID: 27415156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn's Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review.
    Jung ES; Lee SP; Kae SH; Kim JH; Kim HS; Jang HJ
    Gut Liver; 2021 Sep; 15(5):732-741. PubMed ID: 33361549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease.
    Verdejo C; Hervías D; Roncero Ó; Arias Á; Bouhmidi A; Lorente R; Salueña I; Lucendo AJ
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1521-1527. PubMed ID: 30303822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Levels of Fecal Calprotectin 3 Months After Surgery Predict Subsequent Endoscopic Postoperative Remission in Crohn's Disease.
    Veyre F; Boschetti G; Meunier C; Cuerq C; Gay C; Charlois AL; Duclaux-Loras R; Danion P; Cotte E; Kepenekian V; Mialon A; Faure M; Roblin X; Flourie B; Nancey S
    Dig Dis Sci; 2021 Dec; 66(12):4429-4435. PubMed ID: 33387123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn's disease patients with anastomotic strictures.
    Lopes S; Andrade P; Rodrigues-Pinto E; Afonso J; Macedo G; Magro F
    World J Gastroenterol; 2017 Sep; 23(35):6482-6490. PubMed ID: 29085198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Calprotectin for predicting Relapse and Activity in Patients with Crohn's Disease: A Meta-analysis.
    Zhuge Y; Huang QP; Li Q; Wang JS
    Euroasian J Hepatogastroenterol; 2016; 6(2):116-124. PubMed ID: 29201742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin in the prediction of postoperative recurrence of Crohn's disease in children and adolescents.
    Hukkinen M; Pakarinen MP; Merras-Salmio L; Koivusalo A; Rintala R; Kolho KL
    J Pediatr Surg; 2016 Sep; 51(9):1467-72. PubMed ID: 26891835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn's disease: a long-term prospective study.
    Yamamoto T; Shimoyama T; Umegae S; Matsumoto K
    Therap Adv Gastroenterol; 2016 Sep; 9(5):664-70. PubMed ID: 27582878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between Calprotectin and Modified Rutgeerts Score.
    Lopes S; Andrade P; Afonso J; Rodrigues-Pinto E; Dias CC; Macedo G; Magro F
    Inflamm Bowel Dis; 2016 Sep; 22(9):2173-81. PubMed ID: 27482974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Gastroenterological Association-Proposed Fecal Calprotectin Cutoff of 50 ug/g is Associated With Endoscopic Recurrence in a Real-World Cohort of Patients With Crohn's Disease Post-ileocolic Resection.
    Li T; Shah R; Click B; Cohen BL; Barnes E; Joseph A; Bachour S; Hu J; Contreras S; Li E; Axelrad J
    Crohns Colitis 360; 2024 Jan; 6(1):otae016. PubMed ID: 38525200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Calprotectin More Accurately Predicts Endoscopic Remission of Crohn's Disease than Serological Biomarkers Evaluated Using Balloon-assisted Enteroscopy.
    Kawashima K; Ishihara S; Yuki T; Fukuba N; Sonoyama H; Kazumori H; Yamashita N; Tada Y; Kusunoki R; Oka A; Oshima N; Mishima Y; Moriyama I; Kinoshita Y
    Inflamm Bowel Dis; 2017 Nov; 23(11):2027-2034. PubMed ID: 28817462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn's Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography.
    Arai T; Takeuchi K; Miyamura M; Ishikawa R; Yamada A; Katsumata M; Igarashi Y; Suzuki Y
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):56-62. PubMed ID: 27565523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin for evaluating postoperative recurrence of Crohn's disease: a meta-analysis of prospective studies.
    Qiu Y; Mao R; Chen BL; He Y; Zeng ZR; Xue L; Song XM; Li ZP; Chen MH
    Inflamm Bowel Dis; 2015 Feb; 21(2):315-22. PubMed ID: 25569739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic and predictive value of fecal calprotectin and capsule endoscopy for small-bowel Crohn's disease: a systematic review and meta-analysis.
    Xiang B; Dong Z; Dai C
    Rev Esp Enferm Dig; 2021 Mar; 113(3):193-201. PubMed ID: 33207888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is fecal calprotectin an accurate marker in the management of Crohn's disease?
    Vernia F; Di Ruscio M; Stefanelli G; Viscido A; Frieri G; Latella G
    J Gastroenterol Hepatol; 2020 Mar; 35(3):390-400. PubMed ID: 31795013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Assessment of Postoperative Disease Recurrence in Crohn's Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease.
    Furfaro F; D'Amico F; Zilli A; Craviotto V; Aratari A; Bezzio C; Spinelli A; Gilardi D; Radice S; Saibeni S; Papi C; Peyrin-Biroulet L; Danese S; Fiorino G; Allocca M
    Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3143-3151. PubMed ID: 36521739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.